Alegado, Jeicel C.

HRN: 23-12-30  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/31/2023
06/06/2023
IV
55mg
Q8Hrs
Sepsis
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  BloodstreamSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: